Table 13 Influence of infection on the baseline immune function indexes in lung cancer patients

CD3+ (%)

63.40 (54.99，71.20)

66.20 (55.70，70.90)

0.773

CD4+ (%)

35.76 ± 10.57

33.91 ± 11.34

0.312

CD8+ (%)

20.33 (15.30，24.90)

20.30 (15.27，23.66)

0.818

CD4/CD8

1.78 (1.33，2.34)

1.65 (1.18，2.24)

0.437

CD16 + 56+ (%)

17.40 (11.40，26.14)

18.00 (14.70，24.58)

0.495

CD19+ (%)

9.50 (6.18，14.30)

9.56 (5.76，16.50)

0.880

IgM (g/L)

0.83 (0.56，1.08)

0.84 (0.55，1.13)

0.797

L%

15.70 (9.48，22.78)

11.50 (7.00，18.00)

0.019

NLR

4.74 (2.85，8.81)

6.73 (3.92，11.91)

0.017

CRP (mg/L)

17.11 (6.98，63.95)

58.69 (9.25，111.49)

0.025

D-Dimer (mg/L)

3.01 (0.94，5.95)

1.89 (0.88，4.64)

0.183